Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00329498 | L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes | suspended | Phase 2 | 25 | Samsung Medical CenterOTHER | 1 | Oct 26, 2006 | clinicaltrials |
| NCT00393107 | Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab | completed | Phase 2 | 54 | Gruppo Italiano Studio LinfomiOTHER | 1 | Oct 26, 2006 | clinicaltrials |
| NCT00390377 |
| Use of Hair to Diagnose Breast Cancer |
| unknown |
| Phase 2 |
| 240 |
| Fermiscan LtdINDUSTRY |
| 1 |
| Oct 19, 2006 |
| clinicaltrials |
| NCT00261612 | Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma | unknown | Phase 2 | 16 | Medical University of ViennaOTHER | 1 | Oct 18, 2006 | clinicaltrials |
| NCT00300664 | A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. | completed | Phase 2 / Phase 3 | 150 | Royal Marsden NHS Foundation TrustOTHER | 0 | Oct 13, 2006 | clinicaltrials |
| NCT00294476 | IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma | unknown | Phase 2 | 30 | GammaCanINDUSTRY | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00384553 | Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma | unknown | Phase 1 / Phase 2 | 30 | University of MagdeburgOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00385125 | Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL | unknown | Phase 2 | 30 | University of MagdeburgOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00383409 | Multivitamins do Not Improve Radiation Therapy Related Fatigue | completed | Phase 2 | 40 | Faculdade de Medicina do ABCOTHER | 1 | Oct 3, 2006 | clinicaltrials |
| NCT00103545 | Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response | completed | Phase 1 / Phase 2 | 36 | AGO Study GroupOTHER | 1 | Oct 2, 2006 | clinicaltrials |
| NCT00382694 | Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients | unknown | Phase 2 | 80 | Nordic Myeloma Study GroupOTHER | 1 | Sep 29, 2006 | clinicaltrials |
| NCT00333008 | A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status. | unknown | Phase 2 | 27 | The Alvin and Lois Lapidus Cancer InstituteOTHER | 1 | Sep 26, 2006 | clinicaltrials |
| NCT00378755 | Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM | unknown | Phase 2 | 62 | Korean Multiple Myeloma Working PartyOTHER | 1 | Sep 22, 2006 | clinicaltrials |
| NCT00100243 | Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy | completed | Phase 2 | 22 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00291798 | Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane | completed | Phase 2 | 98 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00306553 | Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients | completed | Phase 2 | — | Cytos Biotechnology AGINDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00055432 | Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer | terminated | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Sep 15, 2006 | clinicaltrials |
| NCT00194935 | Weekly Topotecan Therapy in Patients With Ovarian Cancer | terminated | Phase 2 | 32 | Weill Medical College of Cornell UniversityOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00220532 | Folate and Protection Against Cervical Cancer | terminated | Phase 1 / Phase 2 | 180 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00127088 | Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients | suspended | Phase 2 | 37 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00176761 | Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine | terminated | Phase 2 | 27 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00180830 | Glivec Phase II Pediatric Study | terminated | Phase 2 | 36 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 3 | Sep 11, 2006 | clinicaltrials |
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | terminated | Phase 2 | 40 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00138086 | Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma | completed | Phase 2 | 75 | Lymphoma Study AssociationOTHER | 3 | Sep 8, 2006 | clinicaltrials |
| NCT00162669 | Bevacizumab in Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00180947 | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse | unknown | Phase 2 | 210 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00311857 | Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) | unknown | Phase 1 / Phase 2 | 46 | Heidelberg UniversityOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00373620 | A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients | unknown | Phase 2 | 50 | Korean Gynecologic Oncology GroupOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00101842 | Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer | completed | Phase 1 / Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 29, 2006 | clinicaltrials |
| NCT00010829 | Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00026975 | Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients | completed | Phase 2 | 150 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00029783 | Efficacy of Distant Healing in Glioblastoma Treatment | completed | Phase 2 | 150 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00067288 | Meaning-Centered Psychotherapy in Advanced Cancer | completed | Phase 2 | 118 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00070967 | Acupuncture to Improve Quality of Life in Patients With Advanced Cancer | completed | Phase 2 | 40 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00082303 | Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 60 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00356161 | HAI Via Interventionally Implanted Port Catheter Systems | unknown | Phase 2 | 100 | Charite University, Berlin, GermanyOTHER | 1 | Jul 25, 2006 | clinicaltrials |
| NCT00191841 | Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 24, 2006 | clinicaltrials |
| NCT00034502 | A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer. | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 2 | Jul 19, 2006 | clinicaltrials |
| NCT00034606 | Comparing 3 Schedules of Alimta Plus Gemzar | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00034619 | A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00042679 | A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00051493 | ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00097383 | Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 5 | Jul 19, 2006 | clinicaltrials |
| NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | completed | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00350597 | GM-CSF as Adjuvant Therapy of Melanoma | completed | Phase 2 | 50 | Northern California Melanoma CenterOTHER | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00346281 | 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer | unknown | Phase 2 | 15 | pSiMedica LimitedINDUSTRY | 2 | Jun 29, 2006 | clinicaltrials |
| NCT00328237 | Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation | unknown | Phase 2 | 20 | Colorado Blood Cancer InstituteOTHER | 1 | Jun 26, 2006 | clinicaltrials |
| NCT00339586 | First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene | unknown | Phase 2 | 40 | Universitair Ziekenhuis BrusselOTHER | 1 | Jun 21, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Oct 26, 2006source: clinicaltrials